ROCKVILLE, Md., April 19, 2021 /PRNewswire/ -- Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Rhonda Henry has joined the company as President of Emmes BioPharma.
"Naming a leader of our biopharma group is a major, positive step in our strategy to expand and diversify our business," said Dr. Christine Dingivan, Chief Executive Officer of Emmes.